ASTCT and ASGCT hosted their third joint session, concentrating on cellular therapy with sessions given by thought leaders in both organizations. This session aired as an ASTCT Education Session during the 2021 TCT Meetings of ASTCT & CIBMTR.

This session features a panel of experts discussing frequently overlooked topics related to transplantation in underrepresented minorities. This session aired as an ASTCT Education Session during the 2021 TCT Meetings of ASTCT & CIBMTR.

This session examines accelerated aging in the context of cellular therapy and transplantation. To foster an understanding of the role that cellular therapy and transplantation plays in older adults, barriers to treatment from patients’ and providers’ perspectives will be explored. Accelerated aging may be a limitation to proceeding to transplantation or cellular therapy and hamper recovery from this treatment. The session also focuses on the biopathophysiological mechanisms associated with accelerated aging in the context of cellular therapy and transplantation, physical and psychological manifestations of accelerated aging, and impact on survivorship. This session aired as an ASTCT Education Session during the 2021 TCT Meetings of ASTCT & CIBMTR.

Recent advancements in the care of stem cell transplant patients have improved outcomes including survival in this susceptible population. However, there are little data addressing patient-centered outcomes. Outcomes identified by patients and caregivers, termed patient-important outcomes, are crucial to foster health care focused not only on findings that are clinically pertinent but also on findings that are relevant to the patient. Understanding patient-important outcomes allows healthcare delivery systems to prioritize and standardize research, develop patient-important benchmarks and improve outcomes identified by patients. This session aired as an ASTCT Education Session during the 2021 TCT Meetings of ASTCT & CIBMTR.

An expert panel of  experts in transplantation and infectious disease review their experience with the COVID pandemic in centers across the US. Panelists represent major geographic regions with emphasis in center size and location, patient diversity (adult/pediatric) and level of community spread of COVID19.  This session also discusses the scope and activities of TIC-SIG during the pandemic. This session aired as an ASTCT Education Session during the 2021 TCT Meetings of ASTCT & CIBMTR.

This session discusses the state of the art in cord blood graft selection, conditioning, and the prophylaxis and treatment of GVHD and infections for adults and children undergoing CBT. Speakers highlight the clinical practices instituted by transplant centers to improve clinical outcomes and review the current clinical approaches in an effort to facilitate the use of cord blood as source of stem cells for transplantation. This session aired as an ASTCT Education Session during the 2021 TCT Meetings of ASTCT & CIBMTR.

The interactions of behavioral, psychological, and socioenvironmental factors with biological processes (or ‘biobehavioral’) throughout the HCT trajectory significantly impact both psychological and physical morbidity and mortality. Stress-related factors have a well-documented impact on immune function among individuals with cancer and are especially salient in the HCT population given the nature of HCT recovery and survivorship. This sympsoium of the Biobehavioral Research Special Interest Group (SIG) of ASTCT provides an expert overview on the science of individual biobehavioral differences associated with symptoms and outcomes among HCT recipients. This session aired as an ASTCT Education Session during the 2021 TCT Meetings of ASTCT & CIBMTR.

The Survivorship Special Interest Group is pleased to offer a multidisciplinary educational workshop focused on the survivorship and late effect needs of hematopoietic stem cell transplant (HCT) and cellular therapy survivors and their caregivers. As the number of HCT and cellular therapy survivors continues to increase in the coming years, it is essential that healthcare providers are equipped with the knowledge and skills to provide high-quality long-term care for this patient population and their caregivers. In this workshop, participants will have the opportunity to learn from experts in the field through presentations and in round table discussions on topics including, but not limited to the practical aspects of providing appropriate long-term follow-up and survivorship care, evolving telehealth modalities in survivorship care delivery, and development of a research program in HCT and cellular therapy survivorship. The session is open to physicians, advanced care practitioners, nurses, trainees, and other persons in Survivorship.  

The content of this educational session covers reports and final recommendations of the four core working groups of the November 2020 NIH chronic GVHD consensus project. This latest work has been going on since 2019. Almost 100 expert scientists and academic clinicians representing national and international transplant community are contributing to this project which is aiming to fundamentally change our approaches to chronic GVHD therapy, prevention and research over next 5-7 years. This session aired as an ASTCT Education Session during the 2021 TCT Meetings of ASTCT & CIBMTR.

This practical hands on workshop aims to address the current status, therapeutic practices and common patient management dilemmas as recommended by leading clinical experts in the field of chronic GVHD. Currently there are no evidence based detailed clinical management guidelines for chronic GVHD which causes common dilemmas and differences across the wide range of practitioners at the university clinical centers, community hospitals or clinical practices. This session is based on the NIH criteria and how treatment options would look in 2021. This session will review common clinical scenarios and discuss situations considering the latest available evidence. This session aired as an ASTCT Education Session during the 2021 TCT Meetings of ASTCT & CIBMTR.